These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23794037)

  • 1. A solid-state NMR study of amorphous ezetimibe dispersions in mesoporous silica.
    Vogt FG; Roberts-Skilton K; Kennedy-Gabb SA
    Pharm Res; 2013 Sep; 30(9):2315-31. PubMed ID: 23794037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adsorption onto Mesoporous Silica Using Supercritical Fluid Technology Improves Dissolution Rate of Carbamazepine-a Poorly Soluble Compound.
    Gandhi AV; Thipsay P; Kirthivasan B; Squillante E
    AAPS PharmSciTech; 2017 Nov; 18(8):3140-3150. PubMed ID: 28534299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical stability of the amorphous anticholesterol agent (ezetimibe): the role of molecular mobility.
    Knapik J; Wojnarowska Z; Grzybowska K; Hawelek L; Sawicki W; Wlodarski K; Markowski J; Paluch M
    Mol Pharm; 2014 Nov; 11(11):4280-90. PubMed ID: 25310722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of amorphous solid dispersions using 2D solid-state NMR and (1)H T(1) relaxation measurements.
    Pham TN; Watson SA; Edwards AJ; Chavda M; Clawson JS; Strohmeier M; Vogt FG
    Mol Pharm; 2010 Oct; 7(5):1667-91. PubMed ID: 20681586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and physicochemical characterization of surfactant based solid dispersions of ezetimibe.
    Sancheti PP; Karekar P; Vyas VM; Shah M; Pore YV
    Pharmazie; 2009 Apr; 64(4):227-31. PubMed ID: 19435139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of ordered mesoporous silica to enhance the oral bioavailability of ezetimibe in dogs.
    Kiekens F; Eelen S; Verheyden L; Daems T; Martens J; Van Den Mooter G
    J Pharm Sci; 2012 Mar; 101(3):1136-44. PubMed ID: 22190350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Differential Scanning Calorimetry, Powder X-ray Diffraction, and Solid-state Nuclear Magnetic Resonance Spectroscopy for Measuring Crystallinity in Amorphous Solid Dispersions - Application to Drug-in-polymer Solubility.
    Jarrells TW; Munson EJ
    J Pharm Sci; 2022 Oct; 111(10):2765-2778. PubMed ID: 35421430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of a nanocrystalline polymer dispersion of ebselen using solid-state NMR, Raman microscopy, and powder X-ray diffraction.
    Vogt FG; Williams GR
    Pharm Res; 2012 Jul; 29(7):1866-81. PubMed ID: 22367510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Molecular Mobility, Physical State, and Drug Distribution Influence the Naproxen Release Profile from Different Mesoporous Silica Matrices.
    d'Orey P; Cordeiro T; Lourenço MAO; Matos I; Danède F; Sotomayor JC; Fonseca IM; Ferreira P; Correia NT; Dionísio M
    Mol Pharm; 2021 Mar; 18(3):898-914. PubMed ID: 33461296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amorphous stabilization of BCS II drugs using mesoporous silica.
    Tu B; Jonnalagadda S
    Int J Pharm; 2024 Sep; 663():124555. PubMed ID: 39111354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, structural analysis, and properties of tenoxicam cocrystals.
    Patel JR; Carlton RA; Needham TE; Chichester CO; Vogt FG
    Int J Pharm; 2012 Oct; 436(1-2):685-706. PubMed ID: 22841852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17O solid-state NMR as a sensitive probe of hydrogen bonding in crystalline and amorphous solid forms of diflunisal.
    Vogt FG; Yin H; Forcino RG; Wu L
    Mol Pharm; 2013 Sep; 10(9):3433-46. PubMed ID: 23822557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing fluconazole deposition inside mesoporous silica using solid-state NMR spectroscopy: Crystallization of a confined metastable form and phase transformations under storage conditions.
    Nowak M; Dyba AJ; Gołkowska AM; Nieckarz A; Krajewska K; Malec K; Iuga D; Karolewicz B; Khimyak YZ; Nartowski KP
    Int J Pharm; 2023 Oct; 645():123403. PubMed ID: 37716486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Field NMR to Characterize the Crystalline State of Ibuprofen Confined in Ordered or Nonordered Mesoporous Silica.
    Okada K; Hayashi Y; Tsuji T; Onuki Y
    Chem Pharm Bull (Tokyo); 2022; 70(8):550-557. PubMed ID: 35908921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of amorphous drug, 2-benzyl-5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2H-pyridazin-3-one, in silica mesopores and measurement of its molecular mobility by solid-state (13)C NMR spectroscopy.
    Miura H; Kanebako M; Shirai H; Nakao H; Inagi T; Terada K
    Int J Pharm; 2011 May; 410(1-2):61-7. PubMed ID: 21421036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the binding modes and dynamics of histidine on fumed silica surfaces by solid-state NMR.
    Swanson HL; Guo C; Cao M; Addison JB; Holland GP
    Phys Chem Chem Phys; 2020 Sep; 22(36):20349-20361. PubMed ID: 32901618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Perspectives for Fixed Dose Combinations of Poorly Water-Soluble Compounds: a Case Study with Ezetimibe and Lovastatin.
    Riekes MK; Engelen A; Appeltans B; Rombaut P; Stulzer HK; Van den Mooter G
    Pharm Res; 2016 May; 33(5):1259-75. PubMed ID: 26857899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coloration phenomenon of mefenamic acid in mesoporous silica FSM-16.
    Moribe K; Kinoshita R; Higashi K; Tozuka Y; Yamamoto K
    Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):214-8. PubMed ID: 20118582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
    Maleki A; Hamidi M
    Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.